Urine test for prostate cancer
As Europeans live longer, prostate cancer is being diagnosed in a higher proportion of elderly men. As a common form of cancer, it’s also age-related. The disease is common above 65 but infrequent below the age of 40. By 2030, when the proportion of people over 65 will be higher, the number of prostate cancer cases is estimated to quadruple. Early detection is key to reducing the mortality rate. In this context, the EU-funded Nevada project proposes a non invasive urine-based test assay that identifies those men at increased risk of prostate cancer. The project aims to further simplify the test to convert it into a point-of-care assay.
Fields of science
Call for proposalSee other projects for this call